• No results found

[NORMAL] Infectious Dermatology 1

N/A
N/A
Protected

Academic year: 2021

Share "Infectious Dermatology 1"

Copied!
206
0
0

Loading.... (view fulltext now)

Full text

(1)

Dermatological

Infections & Infestations

Mariecon O. Escuadro, MD

Diplomate, Philippine Dermtological Society

(2)

Superficial

Bacterial Skin Infections

1. Impetigo Contagiosa 2. Bullous Impetigo

3. Folliculitis

4. Furuncle & Carbuncle 5. Ecthyma

6. Cellulitis 7. Erysipelas 8. Erythrasma

(3)

Impetigo Contagiosa

• Etiology:

– Staphylococcus aureus: 50-70%

– Streptococcus pyogenes or mixed

• Group A Strep- usual

• Group B Strep- newborn • Group C, G Strep-rare

(4)

Impetigo Contagiosa

• Common sources:

– Adults

• Barbershops, parlors, meat packing plants, swimming pools, infected children

– Children

• Pets, dirty fingernails, daycare, crowded housing and other infected children

(5)

Impetigo Contagiosa

• Clinical Presentation

– Age group: early childhood most common

– Sites: exposed areas (face, hands, neck &

extremities)

– Lesions: starts as 2 mm erythematous

macules-thin-walled vesicles or

bullae-pustules, which rupture: seropurulent

discharge-dries up:

honey-colored/golden-yellow crusts.

(6)

Impetigo Contagiosa

• Complications

– Acute Glomerulonephritis (

Grp A Beta-hemolytic Strep

)

• Incidence: 10-15% with Nephritogenic strains • Prognosis: excellent in children, not as good in

(7)

Bullous Impetigo

• Etiology

– Phage type 71 coagulase positive

Staphylococcus aureus

(8)

Bullous Impetigo

• Clinical Presentation

– Age groups:

– newborn (4th&10th day)

– children

– Sites:

– Face & hands

– Axilla & groin- adults in warm climates

– Lesions:

– Large fragile bullarupture: circinate, weeping or crusted lesions with varnish-like crusts (impetigo circinata)

(9)

Bullous Impetigo

• Constitutional Symptoms:

• Fever & weakness develops • Diarrhea

• Complications:

• Bacteremia • Pneumonia • Meningitis

(10)

Folliculitis

• Etiology

– Staphylococcus aureus

• Clinical Presentation

– Sites:

• Extremities and scalp

• Axillae, thighs, pubis & eyelashes • Gluteal & genital maybe STDs

– Lesions:

(11)

Furuncle & Carbuncle

• Etiology

– Break in the skin (pressure, friction, irritation,

hyperhidrosis, dermatitis, dermatophytosis or

shaving), provides portal of entry of

Staphylococcus aureus

– Autoinoculation from a carrier focus (nose or

groin)

– Predisposing factors: alcoholism, malnutrition,

blood dycrasias, disorder of neutrophil

function, iatrogenic or immunosuppression

(HIV or Diabetes)

(12)

Furuncle & Carbuncle

• Clinical Presentation

– Sites

• Nape, axilla, buttocks

– Lesions

• Furuncle/boil: acute, round, tender, circumscribed perifollicular abscess

• Carbuncle: 2 or more confluent furuncles with multiple opening, +/- purulent discharge

(13)

Furuncle & Carbuncle

• Complications

– Cavernous sinus thrombosis, meningitis &

septicemia (upper lip & nose)

• Treatment

– Warm compress

– Systemic Antibiotics

• Cloxacillin

• 1st gen Cephalosporin

– Surgical: incision (acutely inflamed), incision

& drainage (fluctuant)

(14)

Ecthyma

• Etiology

– Streptococcus

– Staphylococcus aureus- IVD users & HIV

• Predisposing Factors

– Malnutrition

– Poor hygiene

– Trauma

(15)

Ecthyma

• Clinical Presentation

– Sites: shins or dorsal feet

– Lesions: vesicle or vesicopustules- increase

in size-thickly crusted. Removal of crust:

superficial, saucer shaped ulcer w/ elevated

edges & raw base

• (+) scarring

(16)

Cellulitis

• Suppurative inflammation of the subcutaneous

tissue

• Etiology:

– Staphylococcus aureus

– Steptococcus pyogenes

• Predisposing Factors:

– Breaks in the skin

– Tinea pedis- most common portal of entry

– Others: hematologic malignancy, diabetes

(17)

Cellulitis

• Clinical Presentation:

– Lesions: mild local erythema & tenderness

associated with malaise & chilly sensation. +/-

fever & chills

– Erythema spreadswarmth, swelling &

tenderness, +/- pitting on pressure

– Occasionally: vesicles appear, rupture &

discharge purulent material

(18)

Cellulitis

• Complications

– Gangrene, metastaic abscess & sepsis in

children & immunocompromised

• Treatment

(19)

Erysipelas

• Aka St. Anthony’s Fire

• Etiology:

– Grp A Beta hemolytic Strep-supfl dermal

lymphatics

– Strep C or G-occasional

– Grp B Strep- newborns, abdominal or perineal

erysipelas in post partum women

(20)

Erysipelas

• Predisposing Factors

– Break in the skin barrier

– Operative wounds

– Fissures in the nares, auditory meatus, under

the earlobes, on the anus, penis, between or

under the toes (little toe)

– Accidental scalp wounds

– Chronic leg ulcers

(21)

Erysipelas

• Clinical Presentation

– Sites: face & legs

– Prodrome: malaise, chills, high grade fever,

headache, vomiting & joint pains

– Lesions: intensely erythematous (scarlet),

warm, swollen, brawny, well-demarcated

plaque w/ characteristic raised indurated

border

• +/- vesicles/bullae w/ seropurulent fluid • Spread; peripheral extension

(22)

Erysipelas

• Lesions, contd…

• On face: ear may become swollen & distorted; +/- delirium

• Leukocytosis (PMNLs >/= 20,000/mm3)

• Complications:

• Septicemia

• Deep Cellulitis

(23)

Erysipelas

• Treatment

– Systemic: at least 10 days, rapid improvement

in 24-48 hours

– Penicillin V – IV Penicillin – Erythromycin

(24)

Cellulitis & Erysipelas

Cellulitis

Erysipelas

Staphylococcus or Streptococcus

Grp A Streptococcus Subcutaneous Tissue Superficial Dermal

lymphatics

Poorly demarcated Well-demarcated with characteristic raised indurated border

(25)

Erythrasma

• Etiology

– Corynebacterium minutissimum

– Extensive: diabetes or debilitating diseases

• Clinical Presentation

– Sites: intertriginous areas (axilla, genitocrural

crease & the webs between the 4

th

& 5

th

toes>

3

rd

& 4

th

toes; intergluteal cleft, perianal skin,

inframammary area & nails)

(26)

Erythrasma

• Clinical Presentation, contd…

– Lesions:

• asymptomatic except for groin lesions which may present with burning & pruritus

• Sharply delineated, dry, brown, slightly scaling patches

• (+) Coral Red Fluorescence with Wood’s light

(27)

Erythrasma

• Treatment

– Localized

• Topical erythromycin/clindamycin • Topical azoles

• Topical Benzoyl Peroxide Wash or 5% gel

– Widespread

(28)

Mycobacterial Infections

1.

Hansen’s Disease

(29)

Hansen’s Disease

• Mycobacterium leprae

• Classification:

– 1. Indeterminate

– 2. Tuberculoid (TT)

– 3. Borderline Tuberculoid (BT)

– 4. Borderline (BB)

– 5. Borderline Lepromatous (BL)

6. Lepromatous (LL)

(30)

Indeterminate Leprosy

• Solitary, ill-defined hypopigmented macule

or patch

• Sensory: normal or minimally altered

(earliest: sense of cold & light touch)

• Peripheral nerves: not enlarged

• If immunity is good: resolves

spontaneously

(31)

Tuberculoid Leprosy (TT)

• Lesions are solitary, few & asymmetrical

• Lesion: large erythematous plaque w/

sharply elevated border & atrophic center

• Sensory: anesthetic or hyposthetic &

anhidrotic

• Nerve involvement: early, superficial

peripheral nerves are enlarged, tender or

both

(32)

Tuberculoid Leprosy (TT)

• Contracture of fingers (claw hand), facial

muscle paralysis & foot drop may occur

• Interosseous muscles may be atrophied:

wasting of thenar & hypothenar eminences

• Slow skin lesions evolution

• (+) Lepromin skin test, good cell-mediated

immunity

(33)

Tuberculoid Leprosy (TT)

• Histopathology

– Well defined granuloma with Langhans giant

cells, perineural infiltrates, AFB rare

(34)

Borderline Tuberculoid (BT)

• Similar to TT but smaller & more

numerous

(35)

Borderline Leprosy (BB)

• Skin lesions numerous, asymmetrical &

irregularly shaped

(36)

Borderline Lepromatous (BL)

• Lesions are numerous, symmetrical &

small

• Nerve involvement is symmetrical &

appears later

(37)

Lepromatous Leprosy (LL)

• Lesions are ill-defined, infiltrated,

numerous & symmetrical

• Nerve involvement: symmetrical, develops

slowly and at later stages

• Nerve damage: massive bacillary

infiltration w/ compression & fibrosis

• +/- hyperesthesia

(38)

Lepromatous Leprosy (LL)

• Hair: slow progressive hair loss w/ thinning

of outer thrid of eyebrow

• Progressively worsen w/o treatment

• (-) lepromin skin test, poor CMI

(39)

Lepromatous Leprosy (LL)

• Histopathology:

(40)

Hansen’s Disease

• Diagnosis

– Sensory Test- “pin-prick” or “ballpen-point” test

– Skin biopsy stained with Fite –Faraco stain

– Skin slit smears: “ Zieh-Neelsen stain

– Bacteriologic Index’

– Lepromin skin test: immunologic status

6+ >1000 bacilli/f 5+ 100-1000 4+ 10-100 3+ 1-10 2+ 1-10 in 10 OIF 1+ 1-10 in 100 OIF

(41)

Hansen’s Disease

• Diagnosis

– Lepromin skin test: immunologic status

• Fernandez reaction: 24-48 hours • Mitsuda reaction: 4 weeks

(42)

Hansen’s Disease

• Treatment

– Paucibacillary (Indeterminate & TT)

– Multibacillary (BT, BB, BL, LL)

– WHO Protocol:

• 1. Single lesion Paucibacillary

– Single dose: Rifampin 600mg, Ofloxacin 400mg & Minocycline 100mg (ROM)

• 2. Paucibacillary (Indeterminate, TT)

– Rifampin 600mg once a month x 6 months – Dapsone 100mg OD x 6 months

(43)

Hansen’s Disease

WHO Protocol:

• 3. Multibacillary (BT, BB,BL,LL)

– Rifampin 600mg and Clofazimine 300mg once a month – Dapsone 100mg and Clofazimine 50mg OD x 12 months,

or until smear negative

• 4. Special Cases

• For patients who cannot take dapsone & rifampin

– Clofazimine 50 mg , Ofloxacin 400mg & Minocycline 100mg OD x 6mos, – Ffd by: Clofazimine 50mg plus Ofloxacin 400mg OD or Minocycline 100

mg OD x 18 months

• For patients who refuse Clofazimine

– Minocycline 100mg or Ofloxacin 400mg OD x 12 mos or

– Rifampin 600mg, Ofloxacin 400mg & Minocycline 100mg once a mo x 24 months (ROM)

(44)

Hansen’s Disease

Treatment

Dapsone

effective, inexpensive & free of side effects at recommended doses side effects: Methemoglobinemia & anemia (in G6PD deficient); exfoliative dermatitis, hepatitis, neuropathy & agranulocytosis

Rifampin

highly bactericidal, not used as monotherapy to avoid resistance

side effects: red-orange urine, elevated liver enzymes & flu-like lesions

Clofazimine

bacteriostatic & anti-inflammatory

(45)

Hansen’s Disease

• Reactional States

– Acute episodes characterized by remissions &

relapses for a week to a few months in a

chronic course of infection

– Neuritis is the most imptortant consideration

– Precipitating factors: infection, surgery,

physical, physiologic & mental stress,

vaccination, pregnancy, Vitamin A, iodides &

bromides

(46)

Hansen’s Disease

• Reactional States

– 1. Type 1 reaction

• Cell mediated; in BT, BB, BL

• Inflammation (swollen, erythematous & tender) of existing lesions

• No systemic symptoms; mj complication- nerve damage

• a. Reversal- w/ antibiotic tx, shift toward tuberculoid pole

• B. Downgrading- before antibiotic, shift toward lepromatous pole

(47)

Hansen’s Disease

• Reactional States

2. Type 2 reaction/Erythema nodosum

leprosum

• Circulating immune complex-mediated dse;In BL, LL

• Painful, erythematous subcutaneous & dermal nodules

• With systemic symptoms: fever, myalgia, arthralgia, anorexia & iritis

(48)

Hansen’s Disease

• Management of Reactions:

– Type 1 Reversal Mild

• Analgesics

• Chloroquine (1-2weeks)

– Type 1 Reversal Severe

• Prednisone 40-80mg OD x 5-7 days then taper for 2-6 months

• Clofazimine 300mg OD x 6 weeks

– Type 2/ ENL

• Clofazimine 300 mg OD x 6 weeks, 200mg OD x 2-6 mos & 100 mg OD x 1-2 years

• Thalidomide 400mg OD, tapered to 50-100 mg OD in 1 week (teratogenic)

(49)
(50)

Cutaneous TB

• M. tuberculosis, M. bovis

• Classification is based on the mode of

onfection & immunologic state of the host

• Diagnosis is based on clinical

manifestations, histopathologic analyisis,

demonstration of relevant mycobacteria in

tissue or in culture & host reaction

(51)

Cutaneous TB

• 1. Primary Inoculation TB/Tuberculous Chancre/ Tuberculous Primary Complex

• 2. Tuberculous Verrucosa Cutis/Warty TB • 3. Lupus Vulgaris

• 4. Scrofuloderma/TB Colliquativa Cutis

• 5. Orificial TB/TB Ulcerosa Cutis et mucosae

• 6. Others: Tuberculous Gumma, Acute Miliary TB of the skin, Sequelae of BCG inoculation

(52)

Tuberculous Chancre

• Tuberculous chancre & affected regional LN

• Children

• Sites: face, conjunctivae & oral cavity; hands &

lower extremities

• Pathogenesis (MBPB):

– Tubercle bacilli are introduced into the tissue at the site of minor wounds

– Oral lesions caused by bovine bacilli in nonpasteurized milk & after mucosal trauma or tooth extraction

(53)

Tuberculous Chancre

• Chancre (small papule, crust or erosion w/

little tendency to heal) appears 2-4 weeks

after inoculation

• Painless ulcer: shallow w/ a granular or

hemorrhagic base studded w/ miliary

abscess or covered by necrotic tissue;

undermined ragged edges & reddish blue

huemore indurated w/ thick adherent

(54)

Tuberculous Chancre

• Mucosal: painless ulcers or fungating

granulomas

• Slowly progressive, regional LAD x 3-8

weeks after infectionweeks or months:

cold abscess that perforate to surface &

form sinuses

(55)

Tuberculous Chancre

• Histopathology (Fite Stain):

• 3-6 weeks: tuberculoid appearance & caseation

• Diagnosis

– Ulcer w/ little or no tendency to heal

– Unilateral regional LAD

(56)

Tuberculous Chancre

• Course

– Untreated: 12 mos

– Hematogenous spread: bones & joints

– Calcification of regional LN

(57)

Tuberculosis Verrucosa Cutis

• Paucibacillary caused by exogenous re

infection (inoculation) in previously sensitized

individuals w/ high immunity

• Clinical Manifestations:

– Small asymptomatic papule or papulopustule w/ puple inflammatory halo

– Hyperkeratotic

– Slow growth & peripheral expansion verrucous plaque w/ irregular border; solitary

(58)

Tuberculosis Verrucosa Cutis

• Histopathology

– Pseudoepitheliomatous hyperplasia w/ marked

hyperplasia w/ marked hyperkeratosis, a dense

inflammatory infiltrate & abscess in the supfl

dermis or within the pseudoepitheliomatous

rete pegs

– Epitheloid cells & giant cells in upper & middle

dermis

(59)

Lupus Vulgaris

• Chronic, progressive form

• Moderate immunity & a high degree of

tuberculin sensitivity

• Females, 2-3x

• Pathogenesis: post primary, PB caused by

hematogenous, lymphatic or contguous

(60)

Lupus Vulgaris

• Clinical Manifestation

– Sites: nose, cheek, earlobe or scalp

– Initial lesion:

• brownish red, soft or friable macule or papule w/ a smooth or hyperkeratotic surface.

• Apple jelly color on diascopy

– Progression:

• Elevation, deeper brownish color & plaque

• Nasal or auricular cartilage: extensive destruction & disfigurement

(61)

Lupus Vulgaris

• Clinical Manifestation

– Sites: nose, cheek, earlobe or scalp

– Initial lesion:

• brownish red, soft or friable macule or papule w/ a smooth or hyperkeratotic surface.

• Apple jelly color on diascopy

– Progression:

• Elevation, deeper brownish color & plaque

• Nasal or auricular cartilage: extensive destruction & disfigurement

(62)

Lupus Vulgaris

• Diagnosis

– Softness of lesion, brownish red color & slow

evolution

– Apple jelly nodules

• Histopathology

– Typical tubercles

– Secondary changes: epidermal thinning,

atrophy or acanthosis w/ excessive

hyperkeratosis or psedoepitheliomatous

hyperplasia

(63)

Lupus Vulgaris

• Course

– Long term disorder

– Functional impairment & disfigurement

– Squamous Cell CA

(64)

Scrofulderma

• Subcutaneous TB leading to cold abscess

formation breakdown of overlying skin

• MB or PB

• Represents contiguous involvement of

skin overlying another site of infection (TB

lymphadenitis, bones & joints or

epididymitis)

(65)

Scrofulderma

• Site: parotidal, submandibular &

supraclavicular; bilateral

• Lesion: firm, subcutaneous nodule, well

defined, freely movable & asymptomatic

softens, liquefaction w/ perforation

(66)

Scrofulderma

• Histopathology:

• Massive necrosis & abscess formation in center

• Course

(67)

Orificial TB

• Rare TB of mucous membranes

• Autoinoculation

• Underlying Disease: far advanced

pulmonary, intestinal or genitourinary TB

• Clinical Manifestation:

– Small, yellowish or reddish nodules  soft

ulcer w/ typical punched-out appearance,

undermined edges & circular or irregular

border

(68)

Orificial TB

• Clinical Manifestation:

– Multiple yellowish tubercles & bleeds easily

– Edematous & inflamed

– Extremely painful: dysphagia

– Sites:

• TB of Pharynx & Larynx: tongue (tip & lateral

margins), soft & hard palate; lips (advanced cases) • TB of Genitourinary: vulva

(69)

Orificial TB

• Histopathology

– Massive, non-specific inflammatory infiltrate &

necrosis, but tubercles w/ caseation maybe

found

(70)
(71)

Superficial Fungal

Infections

(72)

Dermatophytoses

• Infects non-viable keratinized cutaneous

tissues including stratum corneum, nails &

hair

– Microsporum – Trichophyton

– Epidermophyton

• Factors that promote dermatophytoses

– Environmental

– Immunosuppression – Genetic susceptibility

(73)

Dermatophytoses

• Diagnostics

– KOH smear- septated hyphae

– Histopathology- with PAS & methenamine

silver stains exhibiting septated hyphae within

the stratum corneum

– Fungal cultures

– Wood’s lamp

(74)

Dermatophytoses

• Tinea capitis (ringworm of scalp & kerion)

• Tinea barbae (beard)

• Tinea faciei (face)

• Tinea corporis (body)

• Tinea manus (hands)

• Tinea pedis (feet)

(75)

Tinea Capitis

• Clinical Manifestations

– 1. Non Inflammatory Type

a. Black-dot b. Gray patch

– 2. Inflammatory Type

a. Kerion b. Favus

(76)

Tinea Capitis

• Non-inflammatory Type

– A. Black dot- endothrix; infected hairs broken

off at or below the surface of the scalp

– B. Gray patch- ectothrix; scaly patches with

areas of stubs of broken hair

(77)

Tinea Capitis

• Endothrix: arthrospores are formed inside the

hair shaft; no fluorescence

• T. tonsurans • T. schoenleinii • T. violaceum

• Ectothrix: hair is surrounded w/ sheath of tiny

spores; greenish fluorescence

• Microsporum species • T. verrucosum

• T. mentagrophytes • T. megnini

(78)

Tinea Capitis

• Inflammatory Type

• Begins as erythematous, scaly, papular eruptions w/ loose & broken off hairs

– A. Kerion- localized spot w/ pronounced

swelling, creating a boggy & indurated area

exuding pus

– B. Favus- concave, sulfur-yellow crust

forming around loose wiry hairs

– Hyphae & air spaces within the hairshaft – Bluish-white fluorescence

(79)

Tinea Capitis

• Treatment

– Griseofulvin x 2-4 mos or at least 2 weeks after negative microscopic and culture examinations – Terbinafine 250mg/ Tab x 2 weeks (Trichophyton)

and 4 weeks (Microsporum)

– Itraconazole 100mg/caps, 2 caps/day x 4-6 weeks – Ketoconazole 200mg/tab x 4-6 weeks

– Others: short courses of systemic steroids for

inflammatory type; Selenium sulfide Shampoo or Ketoconazole Shampoo left for 5 mins 3x a week

(80)

Tinea Barbae

• Clinical Manifestations-

usually on the neck

&/or beard area

– 1. Deep Type

(81)

Tinea Barbae

• 1. Deep Type

• Develops slowly

• Does not usually involve the upper lip except the mustache

• Produces nodular thickenings & kerion-like swellings, which are confluent & form diffuse boggy infiltrations w/ abscesses

• Overlying skin is inflamed • Hairs are loose or absent

• Pus may be expressed through the remaining follicular openings

(82)

Tinea Barbae

• 1. Superficial, crusted Type

• Mild pustular folliculitis

– With broken off hairs – Without broken off hairs

• Hairs are loose, dry, brittle & when

extracted, the bulb appears intact

(83)

Tinea Barbae

• Treatment

– Micronized or Ultramicronized Griseofulvin

500-1000mg/ day x 4-6 weeks

– Terbinafine 250mg/ Tab x 2 weeks

(Trichophyton) and 4 weeks (Microsporum)

– Itraconazole 100mg/caps, 2 caps/day x 4-6

weeks

(84)

Tinea Barbae

• Treatment

– Topical Antifungals: miconazole, clotrimazole,

oxiconazole, sulconazole, econazole,

ketoconazole, naftitine, terbinafine, ciclopirox

olamine BID x 2-4 weeks

– Affected areas washed with soap and water

– Healthy areas maybe shaved or clipped

(85)

Tinea Faciei

• Erythematous, slightly scaling patches or

plaques with indistinct borders & with

(86)

Tinea Faciei

• Treatment

– Topical Antifungals: miconazole, clotrimazole,

oxiconazole, sulconazole, econazole,

ketoconazole, naftitine, terbinafine, ciclopirox

olamine BID x 2-4 weeks

– Oral Antifungals:

• Micronized or Ultramicronized Griseofulvin 500-1000mg/ day x 4-6 weeks

• Terbinafine 250mg/ Tab x 2 weeks (Trichophyton) and 4 weeks (Microsporum)

• Itraconazole 100mg/caps, 2 caps/day x 4-6 weeks • Ketoconazole 200mg/tab x 4-6 weeks

(87)

Tinea Corporis

• Sites: neck, upper & lower extremities and

trunk

• Characterized by one or more circular,

sharply circumscribed, slightly

erythematous, dry, scaly plaques w/

central clearing

• Borders are usually elevated & more

inflames & scaly than the central part

(88)

Tinea Corporis

• Lesions may widen to form rings,

sometimes making concentric rings or

rings of intricate patterns (Tinea imbricata)

• Disseminated patches of both dry

(macular) & moist (vesicular) types of

Tinea circinata

(89)

Tinea Corporis

• Treatment

– For Extensive lesions

• Micronized or Ultramicronized Griseofulvin 370-750mg/ day x 4-6 weeks

• Terbinafine 250mg/ Tab x 2 weeks • Itraconazole 200mg/day x 1 week

• Fluconazole 150mg/tab once a week x 4 weeks

– For Localized lesions

• Topical Antifungals: miconazole, clotrimazole, oxiconazole, sulconazole, econazole, ketoconazole, naftitine, terbinafine, ciclopirox olamine BID x 2-4 weeks

(90)

Tinea Cruris

• Aka “Jock Itch”

• Sites: upper & inner surfaces of the thighs

• Begins as a small erythematous and scaling or

vesicular & crusted patch that spreads

peripherally & partly clears in the center

• Curved with well-defined border particularly on

its lower edge

• Border: vesicles, pustules or papules

• Extends: downward- thighs &

backwards-perineum or anus

(91)

Tinea Cruris

• Treatment

– Same as Tinea Corporis

– Reduce perspiration and enhance

evaporation on crural area

– Area should be kept dry by wearing loose

underclothing and trousers, application of

plain talcum powder or antifungal powder

(92)

Tinea Pedis

• Aka “Athelete’s Foot”

• Most common dermatophytosis

• Consists of maceration, slight scaling &

occasional vesiculation & fissures between

& under the toes

• Most common site: third toe web

• If untreated: ulcerative, exudative process

affecting web spaces or entire sole

(93)

Tinea Pedis

• Types:

– 1. Non-inflammatory

• Dull erythema & pronounced scaling (moccasin or

sandal appearance)

– 2. Inflammatory

• Acute vesicular or bullous eruption

• Vesicles contain clear tenacious fluid w/ glycerin consistency which dries up leaving yellowish

brown crusts

(94)

Tinea Pedis

• Treatment

– Reduce perspiration and enhance

evaporation on the interdigital areas

– Toe webs & soles should be dried

immediately after bathing

– Use antiseptic powder on the feet after

bathing ( eg Tinactin powder or Zeasorb

Medicated Powder)

– Plain tlac, cornstarch or rice powder maybe

dusted to the socks & shoes to keep feet dry

(95)

Tinea Pedis

• Treatment

– Severe Tinea Pedis

• Micronized or Ultramicronized Griseofulvin 370-750mg/ day x 4-6 weeks

• Terbinafine 250mg/ Tab x 2 weeks • Itraconazole 200mg/day x 1 week

• Fluconazole 150mg/tab once a week x 4 weeks • *** With severe maceration: One part Aluminum

Acetate to 20 parts of water as dressing

• ***Secondary Infections: Oral or Topical

(96)

Tinea Pedis

• Treatment

– Localized Tinea Pedis

• Topical Antifungals: miconazole, clotrimazole, oxiconazole, sulconazole, econazole,

ketoconazole, naftitine, terbinafine, ciclopirox olamine BID x 2-4 weeks

• Keratolytic Agents (eg Salicylic Acid, Lactic Acid Lotions) for areas protected by thick layers of underlying skin

(97)

Tinea Manum

• Dry, scaling, erythematous or may be

verrucous

(98)

Tinea Manum

• Treatment

– Severe Tinea Manum

• Micronized or Ultramicronized Griseofulvin 370-750mg/ day x 4-6 weeks

• Terbinafine 250mg/ Tab x 2 weeks • Itraconazole 200mg/day x 1 week

• Fluconazole 150mg/tab once a week x 4 weeks • *** With severe maceration: One part Aluminum

Acetate to 20 parts of water as dressing

• ***Secondary Infections: Oral or Topical

(99)

Tinea Manum

• Treatment

– Localized Tinea Manum

• Topical Antifungals: miconazole, clotrimazole, oxiconazole, sulconazole, econazole,

ketoconazole, naftitine, terbinafine, ciclopirox olamine BID x 2-4 weeks

• Keratolytic Agents (eg Salicylic Acid, Lactic Acid Lotions) for areas protected by thick layers of underlying skin

(100)

Onychomycosis

• Types

– 1. Distal Subungal Onychomycosis

– 2. Superficial White Onychomycosis

– 3. Proximal Subungal Onychomycosis

– 4. Candidal Onychomycosis

(101)

Distal Subungal Onychomycosis

• Involves the distal nail bed & hyponychium

w/ sec involvement of the underside of

nailplate

• Whitish-yellowish discoloration starting at

the distal corner of the nail & involves the

junction of the nail & its bed and becomes

brown-black in color

• Later: opaque, thickened, friable & raised

by underlying hyperkeratotic nail bed

(102)

Superficial White Onychomycosis

• Aka Leukonychia Trichophytica

• Invasion of the toenail plate on the surface

producing chalky white nail plate

(103)

Proximal Subungal Onychomycosis

• Involves the proximal nail fold

• White spot appears from beneath the PNF

which gradually fills the lunula & moving

distally

(104)

Candidal Onychomycosis

• Aka Total Dystrophic Onychomycosis

• Involves the whole nail plate

• Fingernails>toenails

• Begins under the lateral & proximal nail

fold & the adjacent cuticle is pink, swollen

& tender on pressure\

• Neighboring nail becomes dark, ridged &

separated from the nail bed

(105)

Candidal Onychomycosis

• Later: total onycholysis

• Nail plate doe not become white, yellow or

friable

• Seen in chronic mucocutaneous

candidiasis

(106)

Onychomycosis Therapy

• Terbinafine 250mg/day x 6 weeks for fingernails

and 12 weeks for toenails

• Itraconazole Pulse Treatment: 200mg BID for 1

week of each month for 2 months for fingernails

and 3 months for toenails

• Fluconazole 150-300mg once a week x 6-12

months

• Griseofulvin 350mg TID with meals x 4-6 months

for fingernails and 10-18 months for toenails

(107)

Dermatophytid

• “Id reaction” to the fungal antigen

especially the inflammatory types

• Diagnosis depends on presence of fungal

infection at site different from the lesion

– Pruritic vesicles on the hand & sides of fingers-most

common site esp of Tinea Pedis

– Acute widespread eruption usually follicular, lichenoid

& scaly papules on the trunk esp of Tinea Capitis

– Erysipelas-like dermatophytid on the shin esp of toe

web tinea

(108)

Pityriasis/Tinea Versicolor

• Etiology:

– Malassezia furfur or Pityrosporum orbiculare

• Short thick fungal hyphae &spores (“spaghetti & meatballs”)

• Clinical Manifestation

– Yellowish or brownish macules in pale skin or hypopigmented macules in dark skin

– Coalesce to form patches

– Delicate scaling (“grattinage”)

(109)

Pityriasis/Tinea Versicolor

• Clinical Manifestation, contd…

– Sites of Predilection

• Sternal region & sides of chest • Abdomen

• Back • Pubis • Neck

• Intertriginous areas

– *** Hypopigmentation- fungus compels production of abnormally small melanosomes which are not

(110)

Pityriasis/Tinea Versicolor

• Diagnosis

– Wood’s Lamp: yellowish or brownish

fluorescence

– Skin Scarping w/ 10% KOH: spaghetti &

meatballs

(111)

Pityriasis/Tinea Versicolor

• Treatment

– 1. Topicals

• Imidazoles- Ketoconazole Shampoo • Selenium Sulfide Shampoos

• Ciclopirox Olamine Shampoo • Zinc Pyrithione Shampoo

• Sulfur Preparations

• Propylene Glycol lotions • Benzoyl Peroxide

(112)

Pityriasis/Tinea Versicolor

• Treatment

– 2. Oral

• Ketoconazole 200 mg/day x 10 days • Fluconazole 400mg single dose

• Itraconazole 200mg x 5-7 days

• *** hypopigmentation will take time to resolve and is not a sign of treatment failure

(113)

Candidiasis

• Aka candidosis, moniliasis, thrush or

oidiomycosis

• Etiology: Candida albicans

• Features:

– Normal inhabitant at various sites (skin, nails, mucous membranes & viscera), until there is some change in the state of the area then it becomes a pathogen

– Areas: perianal and inguinal folds, interdigital, nail folds & axillae

• *** warmth, moisture & maceration permit the organism to thrive

(114)

Candidiasis

• Types:

– 1. Oral – 2. Perleche – 3. Candidal Vulvovaginitis – 4. Candidal Intertrigo – 5. Pseudodiaper rash

– 6. Congenital Cutaneous Candidiasis – 7. Perianal Candidiasis

– 8. Candidal Paronychia

(115)

Oral Candidiasis

• Newborn/ Infant

– Grayish white membranous plaques w/ reddish base on mucous membrane of mouth

– Angles of the mouth

• Adults

– Buccal mucosa and tongue

– Papillae of tongue atrophied w/ smooth, glazed and bright red surface

– *** elderly, debilitated & malnourished – *** often 1st manifestation of HIV

(116)

Oral Candidiasis

• Treatment

– Clotrimazole troches

– Fluconazole 100-200mg/day x 5-10 days

– Itraconazole 200 mg OD x 5-10 days

(117)

Perleche/Angular Cheilitis

• Maceration w/ transverse fissuring of the oral commisures

• Early lesions: ill-defined, grayish white thickened areas w/ slight erythema of mucous membrane at oral

commisure

• More developed lesions: bluish white ot mother of pearl color, contiguous w/ a wedge shaped erythematous

scaling dermatitis of skin portion of commisure fissure, maceration & crust formation

(118)

Perleche/Angular Cheilitis

• Also seen in Riboflavin deficiency & in

malocclusion caused by ill-fitting dentures

• Can be bilateral

(119)

Candidal vulvovaginitis

• Labia: erythematous, moist & macerated

• Cervix: hyperemic, swollen & eroded with

small vesicles on the surface

• Sx: severe pruritus, irriattion, extreme

burning

(120)

Candidal vulvovaginitis

• Pregnancy, In diabetes or secondary to

broad spectrum antibiotic therapy

• Frequent recurrences

(121)

Candidal vulvovaginitis

• Treatment

– Fluconazole 150mg single dose or 100mg/day

x 5-7days

– Itraconazole

– Topical Antifungals

(122)

Candidal Intertrigo

• Arises between folds of genital, in groins

or armpits, between buttocks, under large

pendulous breasts, over hanging

abdominal folds or umbilicus

• Pinkish intertriginous moist patches

surrounded by a thin, overhanging fringe

of macerated epidermis (“collarette of

scale”)

(123)

Pseudo Diaper Rash

• Perianal region spread over entire area

enhanced by maceration produced by wet

diapers

• Scaly macules & vesicles w/ maceration:

pruritus, burning & extreme discomfort

• Erythematous desquamating “satellite” or

“daughter” lesions scattered along edges

(124)

Congenital Cutaneous

Candidiasis

• Infection of an infant during passage

through a birth canal infected with C.

albicans

• Erythematous macules progress to thin

walled pustules, that rupture, dry &

desquamate

• Lesions are widespread, involving even

the nailfolds.

(125)

Perianal Candidiasis

• (+) pruritus ani

• Erythema, oozing & maceration

• Svere pruritus & burning

• Maybe precipitated by oral antibiotic tx

• Treatment:

– Imidazoles

– Topical corticosteroids

– Antipruritic meds

(126)

Candidal Paronychia

• Chronic inflammation of nailfold produces

discharge of pus

• Involves all nail plate

• Cushion-like thickening of paronychial

tissue

• Slow erosion of lateral NF

• Gradual thickening & brownish

discoloration of nailplate

(127)

Candidal Paronychia

• Sual: dishwashers & diabetics

• Treatment

– Oral Fluconazole weekly

– Itraconazole in pulse doses

– Anticandidal lotions

– *** continued for 2-3months to prevent

(128)

Chronic Mucocutaneous

Candidiasis

• Chronic but superficial

• Before age of 6

• Oral Lesions: diffuse perleche & lip

fissures

• Nail: thickened & dystrophic, (+)

paronychia

• Skin: hyperkeratotic, horn-like or

granulomatous lesions

(129)

Chronic Mucocutaneous

Candidiasis

• Adult onset: heralds the occyrence of

Thymoma

(130)

Viral Infections with

(131)

Purely Cutaneous Involvement

• Molluscum contagiosum

• Verruca/Wart

(132)

Molluscum contagiosum

• Etiologic Agent:

– Molluscum contagiosum virus (poxvirus)

• Epidemiology:

– MCV 1: general population

– MCV 2: 60% among HIV patients

– 3 groups: young children, sexually active

adults & immunosuppressed patients (HIV)

– Direct skin to skin contact

(133)

Molluscum contagiosum

• Clinical Presentation

– Lesions:

• smoothed surface, firm, dome-shaped, pearly papules

• 3-5mm in diameter (giant: 1.5cm) • Characteristic: central umbilication

(134)

Molluscum contagiosum

Children

Adults

Usually STD’s Few to >100 <20 lesions

Location: face, trunk & extremities Location: lower abdomen, upper thighs and penile shaft (men)

May occur in genitals as part of wide distribution; if restricted- sexual abuse maybe considered

(135)

Molluscum contagiosum

• Differential Diagnoses

• Wart

• Syringoma (benign sweat gland tumor on face around the eyes)

• Sebaceous hyperplasia (sebaceous gland hyperplasia in seborrheic areas of face) • Basal Cell Carcinoma (skin cancer)

(136)

Molluscum contagiosum

• Complications

– Secondary bacterial infection

– Eczematous reaction in 10% (molluscum dermatitis) – Conjunctivitis or keratitis

– Cutaneous horn (MC cornuatum)

• Histopathology

– Eosinophilic and later basophilic inclusion bodies (Molluscum bodies or Henderson-Paterson

(137)

Molluscum contagiosum

• Diagnosis

– Clinical: centrally umbilicated dome-shaped

lesion

– Diagnostics:

• Cryotherapy: umbilication appears clear against a white (frozen) background

• Shelley’s method for visualization

– Expression of pasty core lesion – Squash between 2 glass slides – Methylene blue stain

(138)

Molluscum contagiosum

• Treatment

– Surgical nicking with comedone extractor*** – Removal by curettage

– Surgical tape after bathing x 16 weeks (90% cure) – Topical Tretinoin 0.05% ODHS

– Imiquimod Cream ODHS*** – TCA 35%-100% application – 10% KOH

– Light cryotherapy

– Anthradin x 4-8 hours

(139)

Molluscum contagiosum

• Treatment, contd…

– Adults w/ genital molluscum

• Mandatory screening for STD • Screen sexual partners

• Cryotherapy

• Podophyllotoxin 0.5% cream BID x 3 days per weeks x 12 weeks

(140)

Molluscum contagiosum

• Course and Prognosis

– Spontaneous resolution in 2-4 months

(141)

Human Papillomavirus/Wart

• Etiologic Agent:

– Human Papillomavirus (HPV)

• 80 types to date

(142)

Human Papillomavirus/Wart

• Clinical Presentation:

– Verruca Vulgaris/Common Wart

– Verruca Plana/ Flat warts

– Verruca Plantaris/ Plantart wart

(143)

Verruca Vulgaris

– Most common: HPV type 2

– Less frequent: HPV type 1,4,7

– Age: 5-20 years old (15% occur after 35) – Children: 5%

– Risk Factors:

• Frequent immersion of hands in water • Meat handlers

(144)

Verruca Vulgaris

-

Spontaneous resolution

- 50% by 1 year

- 60-70% by 2 years

-

Predilection sites

- Hands (fingers & palms)

(145)

Verruca Vulgaris

Lesions

size: pinpoint to 1 cm (ave:5mm) increase in size: weeks to months

elevated, rounded papules with rough, grayish surface

tiny, black dots on surface w/ thrombosed capillaries

(146)

Verruca Plana

– Most common: HPV type 3

– Less frequent: HPV type 10, 27 & 41 – Children & young adults

– Lesions:

• 2-4mm flat topped papules, slightly erythematous or brown on pale skin & hyperpigmented on darker skin

• Generally multiple

• Grouped on face (forehead, cheeks, nose, perioral), neck, dorsa of hands, wrists or knees

(147)

Verruca Plantaris

– Most common: HPV type 1 – Less frequent: HPV type 2, 4

– Appear at pressure points on ball of foot esp midmetatarsal area

– Soft pulpy cores are surrounded by firm, horny ring – Mosaic wart: contiguous warts appearing as one

(148)

Verruca Plantaris

Myrmecia wart:

smooth-surfaced, deep, inflamed & tender papules or plaques on palms or soles, beside or beneath nails or pulp of digits

- dome shaped

- bulkier beneath the surface - HPV 1

(149)

Verruca Plantaris

Ridged wart:

-

peculiar type, HPV 60 - dermatoglyphics persits

- slightly elevated, skin-colored, 3-5mm papules - non weight bearing areas

Plantar verrucous cysts:

-

HPV 60

-1.5-2cm epithelium lined cysts on plantar area -weight bearing areas

(150)

Condyloma Acuminata

• Common sexually transmitted disease

among sexually active young adults

• Infection rate: 50%

• Lifetime risk: 80%

• Subclinical and latent infections-

recurrences & transmission

(151)

Condyloma Acuminata

• Benign Genital Warts: HPV 6 & 11

(152)

Human Papillomavirus/Wart

• Differential Diagnosis:

– Molluscum contagiosum-umbilicated surface

– Syringoma- benign sweat gland tumor of the face – Seborrheic Keratoses-stuck-on hyperkeratotic,

pigmented papules & plaques

– Acrochordon-skin tag; skin-colored, soft exophytic papule

– Callus & corn-maintained skin lines, absent thrombosed capillaries/black dots

(153)

Human Papillomavirus/Wart

• Treatment

– Few lesions

• Light cryotherapy

• Topical Salicylic Acid • Electrodessication

– More extensive

• Topical Tretinoin 30-100% OD-BID • 5 Fluorouracil cream 5% BID

(154)

Human Papillomavirus/Wart

• Treatment

– Refractory

• Pulse dye laser before electrodessication (reduced risk of scarring)

– Genital

• Podophyllin 25% in tincture of benzoin weekly, washed off 4-8 hours later.

• Trichloroacetic acid 35-85% weekly or biweekly. Safe in in pregnancy.

• Cryotherapy w/ liquid nitrogen every 1-3 weeks, 1 or 2 freeze-thaw cycles. Safe in pregnancy.

• Electrofulguration or electrocauterization • Minor surgical removal

(155)

With Systemic Involvement

• Varicella/Chickenpox

• Herpes Zoster/Shingles

• Herpes Simplex

• Measles/Rubeola

• Rubella/German Measles

(156)

Varicella

• Etiology

– Primary infection of VZV

• Epidemiology

– 90%- children <10 years in temperate

countries; adults & adolescents in tropical

– Summer months

(157)

Varicella

• Pathogenesis

– Aerosol or direct contact

– Inoculation of respiratory mucosa replication in

regional nodes (innate defenses)  primary viremia: replication in liver & spleen & RESSecondary

Viremia: mononuclear cells transport virus to skin & mucous membranes (fever & malaise) Virus

released into respiratory secretions replication in epidermal cells

(158)

Varicella

• Clinical Characteristics

– Incubation Period: 10-21 days

– Transmission: direct contact & respiratory

route

– Infectious: 4 days before & 5 days after

exanthem

– Prodrome: low grade fever, malaise &

headache

(159)

Varicella

• Differential Diagnosis

– Drug eruption (drug intake, monomorphous)

– Allergic Contact Dermatitis (symmetrical, localized) – Blistering diseases- Dermatitis Herpetiformis & Linear

IgA dermatoses

• Diagnostics

– Tzank smear- multinucleated giant cells

(160)

Varicella

Congenital

Neonatal

Immuno

compromised

-hypoplastic limbs,

cutaneous scars, ocular & CNS diseases

-extremely severe & even fatal

-necrotic & ulceration

-maternal infections: 20 weeks AOG

-in utero- zoster

postnatally during 1st 2

years of life

-maternal infections: 5 days before & 2 days after delivery

(161)

Varicella

• Treatment

– Antiviral Therapy (Aciclovir, Valaciclovir &

Famciclovir)

• Within 24 hours of appearance of eruption • Acyclovir 800mg 5x a day x 7days

• Valacyclovir 1 gm TID x 5days

– Immunocompromised

• Mild: Aciclovir 800 mg 5x/D x 7-10 days

• Severe: Aciclovir 10mkdose IV q8 x 7 days or longer

• Acyclovir resistant: Foscarnet 40mkdose IV q8 until healed

(162)

Varicella

• Treatment

– Antiviral Therapy (Aciclovir, Valaciclovir &

Famciclovir)

• Within 24 hours of appearance of eruption • Acyclovir 800mg 5x a day x 7days

• Valacyclovir 1 gm TID x 5days

– Immunocompromised

• Mild: Aciclovir 800 mg 5x/D x 7-10 days

• Severe: Aciclovir 10mkdose IV q8 x 7 days or longer

• Acyclovir resistant: Foscarnet 40mkdose IV q8 until healed

(163)

Varicella

• Treatment, contd…

– Supportive: topical antipruritic lotions, oatmeal baths & cool light clothing

– Antibiotics- secondary bacterial infections

• Complications

– Secondary bacterial infection w/ Staph or Strep – Cerebellar ataxia & encephalitis

– Asymptomatic myocarditis & hepatitis – Reye’s syndrome- Aspirin is CI

(164)

Herpes Zoster

• Etiology:

– Varicella Zoster Virus Secondary infection

• Latency in DRG replicates & travels down sensory nerve into skin

• Epidemiology:

– Increases with age, sun exposure, smoking,

trauma, stress & immunocompromised states

(165)

Herpes Zoster

• Classically occurs unilaterally within the

distribution of cranial or spinal sensory

nerve

• Dermatomes:

– Thoracic- 55% – Cranial-20% (Trigeminal) – Lumbar- 15% – Sacral- 5%

(166)

Herpes Zoster

• Clinical Presentation

– Eruption is preceded by pain over affected areas – Papules & plaques of erythema in dermatome,

followed by blisters within hours

– Lesions maybe hemorrhagic, necrotic or bullous – Duration: depends on age, severity of eruption &

underlying immunosuppression ( 2-3 weeks in younger & up to 6 weeks in elderly)

(167)

Herpes Zoster

Pregnancy Disseminated Ophthalmic

-Antivirals: risk-benefit ratio

-> 20 lesions outside the affected dermatome

-Ophthalmic division of CNV

-Acyclovir has been commonly given during pregnancy without direct effect to the fetus

-in old & debilitated -Hutchinson’s Sign: vesicles on side & tip of the nose (external

division of nasociliary nerve w/ involvement of eyeball)

-Usually localized to the skin & does not affect the fetus -fever, protration, headache, signs of meningeal irritation or viral meningitis - Ocular involvement: uveitis (92%) & keratitis (50%)

(168)

Herpes Zoster

• Diagnosis

– Histopathology: intraepidermal vesicles, balloon cells which are degenerated cells of spinous layer, marked intercellular & intracellular edema

• Treatment

– Supportive

:

• Bedrest- prevention of neuralgia in middle aged & elderly

(169)

Herpes Zoster

• Treatment, contd…

– Antiviral Therapy

• Cornerstone in management, reduces zoster-associated pain

• Intitiated within 3-4 days

– Acyclovir 800mg 5x/day x 7days – Valacyclovir 1 gm TID x 7 days – Famciclovir 500 mg TID x 7days

(170)

Herpes Zoster

• Complications

– Ramsay-Hunt Syndrome: facial & auditory nerves

• Herpetic inflammation of geniculate ganglion • Zoster of external ear or tympanic membrane

• Herpes auricularis, facial paralysis & auditory symptoms

– Post herpetic Neuralgia; zoster associated pain until 1 month from resolution of lesions

• Major complication of zoster • Age or severity dependent • Treatment:

– Tricyclic Antidepressants-1st line

– Anticonvulsants: phenothiazines & carbamazepine 200-400mg OD – Gabapentin in escalating doses up to 3200mg OD

(171)

Herpes Simplex

• Etiology

– Orolabial: HSV Type 1

– Genita; : HSV Type 2

• Epidemiology

– One of the most prevalent STI worldwide

– 80% are seropositive for HSV-1

(172)

Herpes Simplex

• Clinical Presentation

– Orolabial Herpes

– Herpetic Whitlow

– Genital Herpes

– Intrauterine & Neonatal Herpes***

– Eczema Herpeticum

(173)

Orolabial Herpes

• High fever, regional lymphadenopathy & malaise

• “Cold sore” or “fever blister”

• Grouped blisters on erythematous base

involving the lips near vermillion border

• Trigger for recurrence: UV exposure

(174)

Herpetic Whitlow

• Infection of the pulp of the fingertip

• Bimodal:

– Children: < 10 years old – Adults: 20-40 years old

• Tenderness & erythema, of lateral nail fold

followed by formation of deep seated blisterd

24-48 hours after

(175)

Genital Herpes

• Spread by skin to skin contact usually during

sexual activity

• Incubation period: 5 days

• Primary Infection

– Grouped blisters & erosions in vagina, rectum or penis w/ continued devt of new lesions over 7-14 days

– Bilaterally symmetrical w/ bilaterally enlarged inguinal LN

(176)

Genital Herpes

• Recurrence

– Prodrome; burning, itching or tingling

– Papules in 24 hoursvesicles in another 24 hours erosions in 24-36 hours and heals in 2-3 days

– Milder than 1st due to antibodies

– Common site: upper buttocks

– Heals without scarring unless secondarily infected – Chronic suppressive therapy- reduces asymtomatic

References

Related documents

Does CCHHS have existing and current job descriptions for any the positions in scope or will the project entail job description development for all positions covered by the

Green Coffee Bean Extract Reduces Fat Accumulation in Green Coffee Bean Extract Reduces Fat Accumulation in Drosophila melanogaster..

Using a spatial working memory task, Azuma and colleagues found lower activation in a parietal region in patients with 22q11 deletion syndrome compared with healthy controls,

The ILO should strive for better cooper- ation with other UN agencies active in the field of equality and non-discrimination, including the Anti- Discrimination Unit in the Office

One of the solutions is to use Energy Maps - a new holistic approach to energy efficiency - an ethical approach that is already helping companies around the world to

Chapter  6  examines  the  role  of  social  networks  in  livelihood  adaptation  strategies  that . smallholders  have  developed  in  response  to  the 

promoting, as implemented by the requirements for the early granting of a permanent residence permit, illustrates the complexity of the current Swiss integration policy and